Application of Metal-Organic Framework Nano-MIL-100(Fe) for Sustainable Release of Doxycycline and Tetracycline

Overview

Journal Nanomaterials (Basel)

Date 2017 Aug 8

PMID 28783087

Citations 12

Authors

Seyed Dariush Taherzade

Janet Soleimannejad

Aliakbar Tarlani

Affiliations

Soon will be listed here.

Abstract

Nanostructures of MIL-100 were synthesized and used as a drug delivery platform for two members of the Tetracycline family. Doxycycline monohydrate (DOX) and Tetracycline hydrochloride (TC) were loaded separately on nano-MIL-100 (nanoparticles of drug@carrier were abbreviated as DOX@MIL-100 and TC@MIL-100). Characterizations were carried out using FT-IR, XRD, BET, DLS, and SEM. The FT-IR spectra revealed that the drugs were loaded into the framework of the carrier. The XRD patterns of DOX@MIL-100 and TC@MIL-100 indicated that no free DOX or TC were present. It could be concluded that the drugs are well dispersed into the pores of nano-MIL-100. The microporosity of the carrier was confirmed by BJH data. BET analysis showed a reduction in the free surface for both DOX@MIL-100 and TC@MIL-100. The release of TC and DOX was investigated, and it was revealed that MIL-100 mediated the drug solubility in water, which in turn resulted in a decrease in the release rate of TC (accelerating in DOX case) without lowering the total amount of released drug. After 48 h, 96 percent of the TC was sustain released, which is an unprecedented amount in comparison with other methods.

Citing Articles

Hollow MIL-125 Nanoparticles Loading Doxorubicin Prodrug and 3-Methyladenine for Reversal of Tumor Multidrug Resistance.

Guo Q, Li J, Mao J, Chen W, Yang M, Yang Y J Funct Biomater. 2023; 14(11).

PMID: 37998115 PMC: 10671911. DOI: 10.3390/jfb14110546.

Deep oxidative desulfurization of model fuels catalysed by immobilized ionic liquid on MIL-100(Fe).

Yang W, Guo G, Mei Z, Yu Y RSC Adv. 2022; 9(38):21804-21809.

PMID: 35518850 PMC: 9066548. DOI: 10.1039/c9ra03035b.

Preparation and characterization of antibacterial dopamine-functionalized reduced graphene oxide/PLLA composite nanofibers.

Li B, Xiong F, Yao B, Du Q, Cao J, Qu J RSC Adv. 2022; 10(32):18614-18623.

PMID: 35518341 PMC: 9053940. DOI: 10.1039/d0ra03224g.

Combined Layer-by-Layer/Hydrothermal Synthesis of FeO@MIL-100(Fe) for Ofloxacin Adsorption from Environmental Waters.

Sturini M, Puscalau C, Guerra G, Maraschi F, Bruni G, Monteforte F Nanomaterials (Basel). 2021; 11(12).

PMID: 34947624 PMC: 8703555. DOI: 10.3390/nano11123275.

Metal-organic frameworks for advanced drug delivery.

He S, Wu L, Li X, Sun H, Xiong T, Liu J Acta Pharm Sin B. 2021; 11(8):2362-2395.

PMID: 34522591 PMC: 8424373. DOI: 10.1016/j.apsb.2021.03.019.

References

Biswas S, Kumari P, Lakhani P, Ghosh B . Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci. 2016; 83:184-202. DOI: 10.1016/j.ejps.2015.12.031. View

Ulbrich K, Hola K, Subr V, Bakandritsos A, Tucek J, Zboril R . Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chem Rev. 2016; 116(9):5338-431. DOI: 10.1021/acs.chemrev.5b00589. View

Horcajada P, Gref R, Baati T, Allan P, Maurin G, Couvreur P . Metal-organic frameworks in biomedicine. Chem Rev. 2011; 112(2):1232-68. DOI: 10.1021/cr200256v. View

Domingues Z, Cortes M, Gomes T, Diniz H, Freitas C, Gomes J . Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrin. Biomaterials. 2003; 25(2):327-33. DOI: 10.1016/s0142-9612(03)00524-6. View

Wu M, Yang Y . Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy. Adv Mater. 2017; 29(23). DOI: 10.1002/adma.201606134. View

Park J, Jiang Q, Feng D, Mao L, Zhou H . Size-Controlled Synthesis of Porphyrinic Metal-Organic Framework and Functionalization for Targeted Photodynamic Therapy. J Am Chem Soc. 2016; 138(10):3518-25. DOI: 10.1021/jacs.6b00007. View

Horcajada P, Serre C, Maurin G, Ramsahye N, Balas F, Vallet-Regi M . Flexible porous metal-organic frameworks for a controlled drug delivery. J Am Chem Soc. 2008; 130(21):6774-80. DOI: 10.1021/ja710973k. View

Galia E, Nicolaides E, Horter D, Lobenberg R, Reppas C, Dressman J . Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res. 1998; 15(5):698-705. DOI: 10.1023/a:1011910801212. View

Allen T, Cullis P . Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2012; 65(1):36-48. DOI: 10.1016/j.addr.2012.09.037. View

10.

Furukawa H, Ko N, Go Y, Aratani N, Choi S, Choi E . Ultrahigh porosity in metal-organic frameworks. Science. 2010; 329(5990):424-8. DOI: 10.1126/science.1192160. View

11.

Horcajada P, Chalati T, Serre C, Gillet B, Sebrie C, Baati T . Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater. 2009; 9(2):172-8. DOI: 10.1038/nmat2608. View

12.

DULBECCO R, Vogt M . Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954; 99(2):167-82. PMC: 2180341. DOI: 10.1084/jem.99.2.167. View

13.

Llopis-Lorente A, Lozano-Torres B, Bernardos A, Martinez-Manez R, Sancenon F . Mesoporous silica materials for controlled delivery based on enzymes. J Mater Chem B. 2020; 5(17):3069-3083. DOI: 10.1039/c7tb00348j. View

14.

Holzwarth U, Gibson N . The Scherrer equation versus the 'Debye-Scherrer equation'. Nat Nanotechnol. 2011; 6(9):534. DOI: 10.1038/nnano.2011.145. View

15.

Mainardes R, Silva L . Drug delivery systems: past, present, and future. Curr Drug Targets. 2004; 5(5):449-55. DOI: 10.2174/1389450043345407. View

16.

Horcajada P, Surble S, Serre C, Hong D, Seo Y, Chang J . Synthesis and catalytic properties of MIL-100(Fe), an iron(III) carboxylate with large pores. Chem Commun (Camb). 2007; (27):2820-2. DOI: 10.1039/b704325b. View

17.

Della Rocca J, Liu D, Lin W . Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc Chem Res. 2011; 44(10):957-68. PMC: 3777245. DOI: 10.1021/ar200028a. View

18.

Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P . Drug delivery systems: An updated review. Int J Pharm Investig. 2012; 2(1):2-11. PMC: 3465154. DOI: 10.4103/2230-973X.96920. View